Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Buti

Showing results (161-170 of 336) with videos related to

Pageof 34
Sort By:
BMC Cancer|June 24, 2024
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma - Meet-URO 33 study (REGAL study)Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2015
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patientsSebastiano Buti, Paola Bordi, Marcello Tiseo, et al.
Clinical Genitourinary Cancer|November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 StudyCristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2023
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitorsFabiana Perrone, Elda Favari, Giuseppe Maglietta, et al.
Cancers|March 10, 2022
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future PerspectivesSara Elena Rebuzzi, Pasquale Rescigno, Fabio Catalano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2022
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinomaMatteo Santoni, Francesco Massari, Marc R Matrana, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2022
Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockadeKazuki Takada, Sebastiano Buti, Melissa Bersanelli, et al.
Diagnostic Cytopathology|July 9, 2015
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patientsCecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, et al.
Cancers|November 13, 2021
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the LiteratureMichela Verzè, Roberta Minari, Letizia Gnetti, et al.
Clinical Genitourinary Cancer|August 4, 2019
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the LiteratureMaria Giuseppa Vitale, Cinzia Baldessari, Michele Milella, et al.
Pageof 34

Showing results (161-170 of 336) with videos related to

Sort By:
Pageof 34
BMC Cancer|June 24, 2024
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma - Meet-URO 33 study (REGAL study)Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2015
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patientsSebastiano Buti, Paola Bordi, Marcello Tiseo, et al.
Clinical Genitourinary Cancer|November 7, 2018
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 StudyCristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2023
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitorsFabiana Perrone, Elda Favari, Giuseppe Maglietta, et al.
Cancers|March 10, 2022
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future PerspectivesSara Elena Rebuzzi, Pasquale Rescigno, Fabio Catalano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2022
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinomaMatteo Santoni, Francesco Massari, Marc R Matrana, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2022
Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockadeKazuki Takada, Sebastiano Buti, Melissa Bersanelli, et al.
Diagnostic Cytopathology|July 9, 2015
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patientsCecilia Bozzetti, Rita Nizzoli, Marcello Tiseo, et al.
Cancers|November 13, 2021
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the LiteratureMichela Verzè, Roberta Minari, Letizia Gnetti, et al.
Clinical Genitourinary Cancer|August 4, 2019
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the LiteratureMaria Giuseppa Vitale, Cinzia Baldessari, Michele Milella, et al.
Pageof 34